Aerpio Pharmaceuticals, Inc.
HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE

Last updated:

Abstract:

The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-.beta.) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-.beta.) inhibitors, and to methods for regulating angiogenesis.

Status:
Application
Type:

Utility

Filling date:

12 Nov 2020

Issue date:

21 Apr 2022